Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Signal Genesys Expands PR Reach Across Four Major U.S. News Networks
-
AbolerIS Pharma Announces First Patient Dosed in Part II of Phase 1 Study of ABO21009, a Novel Anti-CD45RC Antibody, for Rheumatoid Arthritis
-
Broadridge's Distributed Ledger Repo Platform Processes Nearly $9 Trillion in December
-
ViCentra Expands Financing to $98 Million to Accelerate European Commercialization and Ready Next Generation Kaleido Insulin Patch Pump System for U.S. Access
-
TECregen Raises CHF 10 Million in Seed Financing and Appoints Dr. Bo Rode Hansen as Chairman
-
Independent Dutch Study Further Validates Merlin CP-GEP Test for Melanoma Prognosis
-
Droit Launches Decision Decoder
-
Experience Japanese Culture and Art at Keio Plaza Hotel Tokyo through Workshop Program Scheduled from January to April 2026
-
PathAI and University Hospital Zurich Announce Collaboration to Deploy AISight® Dx and AIM-TumorCellularity for Routine Molecular Pathology Workflows
-
Nearly 90 Physicians from MemorialCare's Long Beach Medical Center, Miller Children's & Women's Hospital Recognized by Leading Doctor's Report
-
Binance Launches First Regulated TradFi Perpetual Contracts Settled in Stablecoin, Starting with Gold and Silver
-
FPT Named Sitecore’s First Global Partner Under Global Elite Reseller Program
-
CME Group International Average Daily Volume Reaches Record 8.4 Million Contracts in 2025, Up 8% from 2024
-
Onco3R Therapeutics Appoints Lawrence Blatt as Chair of the Board for Onco3R Therapeutics
-
Engitix Announces $25 Million Series A Extension Financing by Existing Investor Mike Platt to Advance ECM-Targeted Therapeutics in Solid Tumors and Fibrosis
-
Onco3R Therapeutics Appoints Lawrence Blatt as Chair of the Board for Onco3R Therapeutics
-
FIRSTHABIT Wins Grand Award at Global Innovation Forum IR Pitching Competition, Recognized for Next-Generation Learning Technology Vision
-
VGP NV Announces the Launch of a Capped Cash Tender Offer for its Outstanding Green Bonds Due 17 January 2027 and the Intention to Concurrently Issue New Green Bonds
-
Nxera Pharma Licenses Japan and Select Asia-Pacific Rights to Vamorolone for Duchenne Muscular Dystrophy from Santhera Pharmaceuticals
-
Under the Patronage of the Minister of Industry and Mineral Resources - Inauguration of the First Edition of the "Future Minerals Pioneers" Bootcamp
-
Max Stock Limited releases an immediate report on holdings of interested parties and senior officers as of December 31, 2025
-
ISIN DK0030484621 - FRN Tryg Forsikring A/S Subordinated Callable SEK 1,000,000,000 Bond Issue (the "Bonds") - Exercise of Ordinary Call - Key information
-
Gammit International Prepares for Next Phase of Expansion Following
-
How to Choose the Right Term Insurance Plan if You Are an NRI
-
Bayer and Soufflé Therapeutics Announce Strategic Collaboration to Advance Cell-Specific Heart-Targeted siRNA Therapy
-
Crédit Agricole Assurances announces the launch of a tender offer for two series of subordinated fixed rate resettable notes and its intention to issue Tier 2 subordinated notes
-
Quadient Achieves A- Rating from CDP, Marking a Major Milestone in Its ‘Elevate to 2030’ Climate Ambition
-
VestoFX.net: Globale Aktienindizes im Überblick vor 2026
-
Grace in Motion: A Night That Moves Scottsdale to Support Mothers in Crisis
-
SOITEC BOARD OF DIRECTORS APPOINTS LAURENT RÉMONT CHIEF EXECUTIVE OFFICER, EFFECTIVE APRIL 2026
-
Director Declaration
-
Santhera Licenses AGAMREE® (Vamorolone) to Nxera Pharma in Japan, South Korea, Australia and New Zealand in a Deal Valued at up to USD 205 Million Plus Royalties
-
Regarding the appointment of an independent member to the EPSO-G Nomination and Remuneration Committee
-
CES 2026 Highlight Debut: Daimon Robotics' DM-EXton2, the World's First Haptic Feedback Teleoperation Data Acquisition System
-
Luminor provides EUR 17 million in financing for four commercial projects developed by companies managed by AB Tewox
-
Singapore: The Longevity Lab Reimagining Human Life Extension
-
Wearable sensors assist in developing safer and better home dialysis - HUS and VTT start testing with patients
-
CMR Surgical receives CE Mark for use of Versius in paediatric surgery
-
CES 2026 | Autolink and Tata Elxsi Sign MoU to Accelerate Software Defined Vehicle Adoption for Global OEMs
-
Getlink: Shuttle Traffic in December 2025
-
Natus Sensory Appoints Arne Boye Nielsen to Board of Directors
-
Maurel & Prom: Biannual Update on the Liquidity Agreement
-
Allotex Advances from European Commercialization to U.S. Clinical Phase
-
Gold Production for YE 2025 and Award of Impact Benefit Agreement (“IBA”)
-
Solana Accelerate Joins Consensus Hong Kong, Bringing Web3's Most Dynamic Community to Asia's Premier Crypto Gathering
-
Shell fourth quarter 2025 update note
-
Gold Production for YE 2025 and Award of Impact Benefit Agreement (“IBA”)
-
Eleva appoints Erich Rajkovic as new Chief Business Officer
-
Tensive reports positive pivotal trial top-line results showing REGENERA™ bioresorbable device may transform breast reconstruction
-
Orosur Mining Inc Announces Anzá Restarts With Strong Set of Drilling Results
